S. Natarajan‐Amé

发表

Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

A. Vekhoff, E. Solary, M. Mohty, 2022, Clinical and Experimental Medicine (Testo stampato).

Fungal Infections in Patients With Neutropenia

O. Lortholary, R. Herbrecht, V. Letscher-Bru, 2000, Drugs & Aging.

The lipid formulations of amphotericin B

R. Herbrecht, V. Letscher-Bru, Y. Nivoix, 2003, Expert opinion on pharmacotherapy.

Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B

R. Herbrecht, A. Zamfir, V. Letscher-Bru, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Management of systemic fungal infections: alternatives to itraconazole.

R. Herbrecht, V. Letscher-Bru, Y. Nivoix, 2005, The Journal of antimicrobial chemotherapy.

Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients.

J. Bergerat, P. Dufour, Kun Liu, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients.

J. Bergerat, P. Lutun, M. Velten, 2006 .

Factors associated with overall and attributable mortality in invasive aspergillosis.

Philippe Lutun, Bruno Lioure, Karin Bilger, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fatal Aspergillus fumigatus Myositis in an Immunocompetent Patient

J. Sibilia, R. Herbrecht, R. Javier, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome

T. Frebourg, J. Limacher, J. Bergerat, 2001, International journal of cancer.

Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease

D. Antoni, G. Noel, P. Meyer, 2013, Radiation Oncology.

Sensitivity to cisplatin treatment of human K1 thyroid carcinoma cell lines with altered p53 function

J. Céraline, G. Deplanque, J. Bergerat, 2002, Cancer Chemotherapy and Pharmacology.

Invasive Pulmonary Aspergillosis

R. Herbrecht, V. Letscher-Bru, M. Canuet, 2004, Seminars in respiratory and critical care medicine.

Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia.

L. Fornecker, R. Herbrecht, V. Letscher-Bru, 2005, Medical mycology.

Multiple vertebral osteonecrosis.

J. Dietemann, T. Moser, J. Kuntz, 2008, Joint, bone, spine : revue du rhumatisme.

Oral chemotherapy in colorectal cancer treatment: review of the literature.

E. Andrès, P. Dufour, J. Kurtz, 2003, European journal of internal medicine.

Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS?

A. Stamatoullas, A. Levis, P. Fenaux, 2013, Blood.

Long‐term survival in post‐transplant lymphoproliferative disorders with a dose‐adjusted ACVBP regimen

J. Bergerat, P. Lutun, R. Herbrecht, 2006, British journal of haematology.

Bortezomib combined with low‐dose cytarabine in Intermediate‐2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM

A. Stamatoullas, P. Fenaux, L. Adès, 2012, British journal of haematology.

Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib

D. Levêque, G. Becker, K. Bilger, 2020, Clinical Pharmacokinetics.

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

M. Cazzola, H. Deeg, R. Schlenk, 2020, Leukemia.

Latent acute promyelocytic leukemia t(15;17)(q22;q12-21) and sarcoidosis: long-term cohabitation.

P. Dufour, M. Lessard, A. Falkenrodt, 2005, European journal of internal medicine.

Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease

D. Antoni, G. Noel, P. Meyer, 2013, Radiation oncology.

Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera.

L. Fornecker, R. Herbrecht, F. Maloisel, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

S. Chevret, P. Fenaux, S. Thépot, 2022, Leukemia.

Treatment of myelodysplastic syndromes with excess of blasts by bevacizumab is well tolerated and is associated with a decrease of VEGF plasma level

L. Mannone, P. Fenaux, N. Vey, 2011, Annals of Hematology.

Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

A. Vekhoff, E. Solary, M. Mohty, 2022, Clinical and Experimental Medicine.

Ferritin level at diagnosis is not correlated with poorer survival in non RBC transfusion dependent lower risk de novo MDS.

A. Stamatoullas, P. Fenaux, N. Vey, 2011, Leukemia research.